The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Final analysis of phase II study of EZN-2208 (PEG-SN38) in metastatic breast cancer (MBC).
Cynthia R. C. Osborne
No relevant relationships to disclose
Joyce O'Shaughnessy
No relevant relationships to disclose
Frankie Ann Holmes
No relevant relationships to disclose
Hyun Sue Kim
No relevant relationships to disclose
Darren M. Kocs
No relevant relationships to disclose
Michael S. Steinberg
No relevant relationships to disclose
Paul D. Richards
No relevant relationships to disclose
Svetislava J. Vukelja
No relevant relationships to disclose
Noah C. Berkowitz
Stock Ownership - Enzon
Aby Buchbinder
Stock Ownership - Enzon